<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Intervet has developed Bluetongue vaccine</title><link>/b/veterinary-news/posts/intervet-has-developed-bluetongue-vaccine</link><description> Intervet International bv, part of Schering-Plough Corporation, has 
developed a vaccine against Bluetongue serotype 8, for sheep and cattle. The 
vaccine has been taken into production now. Intervet is aiming to deliver the 
first quantities of vaccine</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>